Latest News & Features
Big Pharma
The European Patent Office has revoked a patent covering biotechnology company Celgene’s cancer drug Revlimid. 12 May 2015
Asia
The Indian Patent Office has rejected Johnson & Johnson subsidiary Janssen Pharmaceutica’s application to patent its HIV drug Edurant, according to a report by The Financial Express. 12 May 2015
Americas
The Supreme Court of California has ruled that so-called “pay-for-delay” patent settlements can be challenged under state antitrust law in a case centering on Bayer’s antibiotic drug Cipro. 11 May 2015
Americas
Law firm Burns & Levinson has expanded its intellectual property practice with the hire of life sciences attorneys John Hamilton and Gabriel Goldman. 11 May 2015
Americas
The US Court of Appeals for the Federal Circuit has blocked US sales of Sandoz’s Zarxio, the biosimilar version of Amgen’s Neupogen, an injection used to prevent infection in patients undergoing chemotherapy. 7 May 2015
Americas
The US Court of Appeals for the Federal Circuit has rejected a man’s claim that he was stopped from entering the fitness machine market because he feared infringing patents that were eventually found to be falsely attributed to Nautilus. 7 May 2015
Americas
The US Supreme Court has rejected pharmaceutical company Bristol-Myers Squibb’s appeal to review a ruling that found its patent covering a treatment for hepatitis B invalid. 6 May 2015
Americas
Law firm Fish & Richardson has added patent attorney Lisa Chiarini to its intellectual property litigation group. 5 May 2015
Big Pharma
The English High Court has ruled that a patent covering Novartis’s transdermal patch treatment for Alzheimer’s disease, Exelon, is invalid. 29 April 2015
Americas
A US court has ruled on how five claims in two patents related to acne drug Absorica should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis. 28 April 2015